| Serial Number | 87937170 |
| Word Mark | AFFIMER XT |
| Filing Date | Friday, May 25, 2018 |
| Status | 606 - ABANDONED - NO STATEMENT OF USE FILED |
| Status Date | Monday, July 4, 2022 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, April 7, 2020 |
| Goods and Services | Reagents for use in veterinary and medical diagnostic tests except tests in the field of immunohematology and transfusion medicine; reagents for use in medical and veterinary research except tests in the field of immunohematology and transfusion medicine; diagnostic reagents for use in medical and veterinary screening except tests in the field of immunohematology and transfusion medicine; diagnostic reagents for medical and veterinary diagnostic purposes for use in assays of biological samples, particularly blood except tests in the field of immunohematology and transfusion medicine; diagnostic reagents for medical and veterinary diagnostic purposes for use in assays of samples, particularly blood except tests in the field of immunohematology and transfusion medicine; diagnostic preparations for medical and veterinary diagnostic purposes for use in relation to food intolerance testing; pharmaceutical substances based on affinity reagents equivalent to antibodies, and products comprising them, all for use in medical and/or veterinary screening except tests in the field of immunohematology and transfusion medicine; pharmaceutical preparations in the nature of antigens for medical diagnostic use and veterinary diagnostic use and/or pharmaceutical purposes for the detection of cancer, inflammatory diseases, food allergies, infections, autoimmune disorders and for immunity testing but not immunohemotology and transfusion medicine; diagnostic and/or pharmaceutical preparations containing antigens except preparations in the field of immunohematology and transfusion medicine, for use in medical and veterinary treatment in the nature of anti-infectives, cancer immunotherapies, anti-inflammatory diseases, and genetic conditions; pharmaceutical preparation in the nature of substrates impregnated with or carrying antigens for medical diagnostic use and veterinary diagnostic use and pharmaceutical purposes other than immunohematology and transfusion medicine for the detection of cancers, inflammatory diseases, food allergies, infections, autoimmune disorders and for immunity testing; affinity reagents, namely, protein binding agents equivalent to antibodies for medical diagnostic use and veterinary diagnostic use and/or pharmaceutical purposes for the detection of cancers, inflammatory diseases, food allergies, infections, autoimmune disorders and for immunity testing but not immunohematology and transfusion medicine; pharmaceutical or diagnostic preparations containing affinity reagents, namely, protein binding agents equivalent to antibodies except in connection with immunohematology or transfusion medicine for medical diagnostic use and veterinary diagnostic use in the nature of anti-infectives, cancer immunotherapies, anti-inflammatory diseases and genetic conditions; pharmaceutical preparations in the nature of substrates impregnated with or carrying affinity reagents, namely, protein binding agents equivalent to antibodies for medical diagnostic use and veterinary diagnostic use in the nature of anti-infectives, cancer immunotherapies, anti-inflammatory diseases and genetic conditions; wound dressings; medical plasters; antiseptic wipes; diagnostic reagents for medical use except in connection with immunohematology and transfusion medicine containing any of the aforesaid products; food intolerance test kits comprising diagnostic test patches for application to the skin for determining allergies; reagents, namely, protein binding agents for use in scientific research; reagents, namely, protein binding agents for use in scientific screening; genetic testing kits comprised of reagents for medical purposes; genetic testing kits comprised of reagents for medical purposes for animals; genetic testing kits comprised of reagents for medical purposes; genetic testing kits comprised of reagents for medical purposes for animals |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Sunday, June 3, 2018 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Avacta Limited |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | Wetherby LS237FA GB |
| Party Name | Avacta Limited |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | Wetherby LS237FA GB |
| Event Date | Event Description |
| Tuesday, July 5, 2022 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| Monday, July 4, 2022 | ABANDONMENT - NO USE STATEMENT FILED |
| Saturday, December 4, 2021 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Thursday, December 2, 2021 | SOU EXTENSION 3 GRANTED |
| Thursday, December 2, 2021 | SOU EXTENSION 3 FILED |
| Thursday, December 2, 2021 | SOU TEAS EXTENSION RECEIVED |
| Thursday, May 27, 2021 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Tuesday, May 25, 2021 | SOU EXTENSION 2 GRANTED |
| Tuesday, May 25, 2021 | SOU EXTENSION 2 FILED |
| Tuesday, May 25, 2021 | SOU TEAS EXTENSION RECEIVED |
| Thursday, December 3, 2020 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Tuesday, December 1, 2020 | SOU EXTENSION 1 GRANTED |
| Tuesday, December 1, 2020 | SOU EXTENSION 1 FILED |
| Tuesday, December 1, 2020 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, June 2, 2020 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, April 7, 2020 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, April 7, 2020 | PUBLISHED FOR OPPOSITION |
| Wednesday, March 18, 2020 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Saturday, February 29, 2020 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Thursday, February 6, 2020 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, February 6, 2020 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, February 6, 2020 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, August 6, 2019 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Tuesday, August 6, 2019 | NON-FINAL ACTION E-MAILED |
| Tuesday, August 6, 2019 | NON-FINAL ACTION WRITTEN |
| Monday, July 29, 2019 | PREVIOUS ALLOWANCE COUNT WITHDRAWN |
| Tuesday, June 18, 2019 | WITHDRAWN FROM PUB - OG REVIEW QUERY |
| Monday, June 3, 2019 | ELECTRONIC RECORD REVIEW COMPLETE |
| Friday, May 31, 2019 | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED |
| Thursday, May 23, 2019 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, May 15, 2019 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, May 15, 2019 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, May 15, 2019 | ASSIGNED TO LIE |
| Wednesday, May 8, 2019 | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED |
| Wednesday, April 10, 2019 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| Wednesday, April 10, 2019 | LETTER OF SUSPENSION E-MAILED |
| Wednesday, April 10, 2019 | SUSPENSION LETTER WRITTEN |
| Wednesday, March 20, 2019 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, March 20, 2019 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, March 20, 2019 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, September 24, 2018 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, September 24, 2018 | NON-FINAL ACTION E-MAILED |
| Monday, September 24, 2018 | NON-FINAL ACTION WRITTEN |
| Saturday, September 15, 2018 | ASSIGNED TO EXAMINER |
| Sunday, June 3, 2018 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, May 29, 2018 | NEW APPLICATION ENTERED |